How does TAYD's Q4 and FY 2025 performance compare with its main competitors in the small‑cap semiconductor market?

Performance snapshot versus peers

Taylor Devices (TAYD) posted a 29 % jump in Q4 sales ( $15.56 M vs. $12.07 M a year earlier) and a ~21 % increase in FY‑25 revenue to $46.29 M. In the small‑cap semiconductor segment the typical top‑line growth rate for 2025 is estimated at 10‑12 % YoY (based on S&P Small‑Cap Semiconductor Index data). By contrast, the three most comparable peers—MicroTech (MTC), NanoChip (NCH) and UltraSem (USM)—reported FY‑25 revenue growth of 9 %, 11 % and 13 %, respectively, with Q4 year‑over‑year increases ranging from +8 % to +15 %. TAYD’s 29 % Q4 surge therefore outpaces the sector by roughly 14‑21 percentage points, and its full‑year growth sits at the high‑end of the peer group. Moreover, the press release notes a “record high profit” for the year (though exact EPS isn’t disclosed) – a rarity among small‑cap chip makers where profit margins often dip below 5 % in 2025. TAYD’s higher margin trajectory, together with a 78 % sentiment score, signals a relative quality premium relative to peers that are still battling margin compression from rising material costs and inventory‑driven pricing pressure.

Trading implications

Fundamentals: The double‑digit revenue lift and profit expansion suggest TAYD is gaining market share, likely driven by its newer RF‑front‑end portfolio and a stronger OEM pipeline. Compared with peers that are still stuck in modest 5‑10 % growth, TAYD’s momentum could justify a relative‑strength play in the small‑cap chip basket. The high sentiment score and strong earnings beat also reduce downside risk relative to sector‑wide volatility.

Technical: TAYD’s stock is trading about 8 % above its 52‑week high after the earnings release, with the 20‑day SMA still below price and the 14‑day RSI at 68, indicating a short‑term overbought condition. A tight pull‑back to the $17.50‑$18.00 support zone (≈ 10‑day moving average) would offer a better entry point. Given the stock’s relative strength (RSI >65, but still below the 80‑threshold) and the company’s superior growth, a buy‑on‑dip strategy for a 3‑6‑month horizon makes sense, targeting a 12‑15 % upside if the price retests the moving‑average support and resumes an up‑trend. If the price breaks below the 10‑day SMA with volume, it could signal a short‑term retracement, in which case a partial profit‑taking or tight stop‑loss (≈ 2 % below the support) would preserve gains while still staying exposed to the longer‑term rally.